About Luzerne Life Sciences Private Limited
Data last updated:
Luzerne Life Sciences Private Limited is a private limited company based in Kochi, Kerala, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 September 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U33110KL2014PTC037223. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1.14 Cr and a paid-up capital of ₹1.14 Cr. It is led by directors Deepu Mathew (Managing Director) and Sajin Stalin.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at 64/5442 Cosmo Tower Avenue – 2 Road Kathrikadavu Kaloor, Kochi, Kerala, India – 682017.
As per the financials filed for FY 2020, the company reported a revenue of ₹4.21 Cr, a growth of 43% compared to the previous year. For the same year it recorded a net profit of ₹8.1 Lakh (net margin 1.9%) and EBITDA of ₹19 Lakh (EBITDA margin 4.5%). Revenue has grown at a compounded annual rate (CAGR) of 31% over three years and 114% over five years.
The company has about 2 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1.08 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website luzerne.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address64/5442 Cosmo Tower Avenue – 2 Road Kathrikadavu Kaloor, Kochi, Kerala, India – 682017
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Luzerne Life Sciences Private Limited
The main business activity of Luzerne Life Sciences is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Luzerne Life Sciences Private Limited
Luzerne Life Sciences Private Limited is audited by VIJEESH V R for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| VIJEESH V R | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Luzerne Life Sciences Private Limited
Luzerne Life Sciences has 2 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sajin Stalin | Director | 23 Aug 2019 | 7 Years 1 Months | Current |
| Deepu Mathew | Managing Director | 23 Aug 2019 | 7 Years 1 Months | Current |
Financials of Luzerne Life Sciences Private Limited FY 2020 filings available
Luzerne Life Sciences Private Limited reported revenue of ₹4.21 Cr (up 43% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR) of Luzerne Life Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 114% over five years, including 43% growth in the latest year. EBITDA rose 48% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Luzerne Life Sciences Private Limited
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹4.21 Cr | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹19 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹8.1 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Luzerne Life Sciences Private Limited
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Luzerne Life Sciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Luzerne Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Luzerne Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Apr 2021 | Canara Bank | ₹14.5 Lakh | Open |
| 23 Apr 2021 | Canara Bank | ₹18 Lakh | Open |
| 09 Jul 2015 | Canara Bank | ₹75 Lakh | Open |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Luzerne Life Sciences Private Limited
Luzerne Life Sciences Private Limited has a workforce of 2 employees as of Apr 08, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Luzerne Life Sciences Private Limited
Luzerne Life Sciences has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Luzerne Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Luzerne Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Luzerne Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Luzerne Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Luzerne Life Sciences Private Limited
Frequently Asked Questions about Luzerne Life Sciences Private Limited
Luzerne Life Sciences is an active private limited company based in Kochi, Kerala, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 September 2014 (12+ years old) and is registered under CIN U33110KL2014PTC037223.
Luzerne Life Sciences reported revenue of ₹4.21 Cr for FY 2020 (up 43% YoY).
Luzerne Life Sciences has 2 current directors:
- Deepu Mathew - Managing Director
- Sajin Stalin - Director
Luzerne Life Sciences reported a net profit of ₹8.1 Lakh (net margin 1.9%) and EBITDA of ₹19 Lakh (EBITDA margin 4.5%) for FY 2020, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Luzerne Life Sciences is 31% over three years and 114% over five years. In the latest year (FY 2020) revenue rose 43%. CAGR is the steady yearly rate that links the first and the last year.
No. Luzerne Life Sciences has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Luzerne Life Sciences is U33110KL2014PTC037223. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Luzerne Life Sciences was incorporated on 04 September 2014, making it 12+ years old. It is registered with the Registrar of Companies, Ernakulam.
Luzerne Life Sciences can be reached through the website luzerne.in. Its registered office is in Kochi, Kerala, India.